Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brostallicin and Cisplatin in Metastatic TNBC
NCT01091454Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Jun 2010
- Primary completion
- Jun 2012
- Modality
- DNA Intercalators/Alkylators, Recombinant Proteins and Enzymes, Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of brostallicin in triple-negative breast cancer (TNBC), sponsored by Cancer and Leukemia Group B. Started Jun 2010; status: completed.
02
Drugs
brostallicin
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT01091454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01091454.